UNIGENE LABORATORIES INC Amortization
UNIGENE LABORATORIES INC reported Amortization of -$447.02 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2013-05-14
- UNIGENE LABORATORIES INC amortization for the quarter ending 2013-03-31 was -$447.02K.
- UNIGENE LABORATORIES INC amortization for the quarter ending 2012-12-31 was -$1.03M.
- UNIGENE LABORATORIES INC amortization for the quarter ending 2012-09-30 was -$611.55K.
- UNIGENE LABORATORIES INC amortization for the quarter ending 2012-06-30 was -$940.07K.
- UNIGENE LABORATORIES INC amortization for fiscal 2012 was -$2.95M.
- UNIGENE LABORATORIES INC amortization for fiscal 2011 was -$10.92M.
- UNIGENE LABORATORIES INC amortization for fiscal 2010 was -$1.33M, a 197.00% decline from fiscal 2009.
- UNIGENE LABORATORIES INC amortization for fiscal 2009 was $1.37M.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2013-03-31 | -$447.02K 10-Q · filed 2013-05-14 | -$1.48M derived: sum of 2 quarters · filed 2013-05-14 | -$2.09M derived: sum of 3 quarters · filed 2013-05-14 | -$3.03M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2012-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.64M derived: sum of 2 quarters · filed 2013-03-15 | -$2.58M derived: sum of 3 quarters · filed 2013-03-15 | -$2.95M 10-K · filed 2013-03-15 | |
| 2012-09-30 | -$611.55K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | -$1.55M derived: sum of 2 quarters · filed 2013-01-31 | -$1.92M 10-Q · filed 2013-01-31 | -$10.65M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2012-06-30 | -$940.07K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-01-31 | -$1.31M 10-Q/A · filed 2013-01-31 | -$10.04M derived: sum of 3 quarters · filed 2013-05-14 | -$10.80M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2012-03-31 | -$365.62K 10-Q · filed 2013-05-14 | -$9.10M derived: sum of 2 quarters · filed 2013-05-14 | -$9.86M derived: sum of 3 quarters · filed 2013-05-14 | -$10.68M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$9.50M derived: sum of 2 quarters · filed 2013-03-15 | -$10.32M derived: sum of 3 quarters · filed 2013-03-15 | -$10.92M 10-K · filed 2013-03-15 | |
| 2011-09-30 | -$759.54K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | -$1.58M derived: sum of 2 quarters · filed 2013-01-31 | -$2.19M 10-Q · filed 2013-01-31 | -$2.50M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-06-30 | -$823.14K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-01-31 | -$1.43M 10-Q/A · filed 2013-01-31 | -$1.74M derived: sum of 3 quarters · filed 2013-03-15 | -$2.05M derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-03-31 | -$602.85K 10-Q/A · filed 2013-01-31 | -$915.55K derived: sum of 2 quarters · filed 2013-03-15 | -$1.23M derived: sum of 3 quarters · filed 2013-03-15 | ||
| 2010-12-31 | -$312.69K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$625.38K derived: sum of 2 quarters · filed 2013-03-15 | -$1.33M 10-K · filed 2013-03-15 | ||
| 2010-09-30 | -$312.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$1.01M 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | -$701.24K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | $1.37M 10-K/A · filed 2013-01-31 | -$1.37M 10-K · filed 2012-03-15 |